Previous Article | Next Article 
Journal of Virology, December 2003, p. 12764-12772, Vol. 77, No. 23
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.23.12764-12772.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines
Wing-Pui Kong,1 Yue Huang,1 Zhi-Yong Yang,1 Bimal K. Chakrabarti,1 Zoe Moodie,2 and Gary J. Nabel1*
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-3005,1
Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-10242
Received 16 April 2003/
Accepted 26 August 2003
The ability to elicit an immune response to a spectrum of human immunodeficiency virus type 1 (HIV-1) gene products from divergent strains is a desirable feature of an AIDS vaccine. In this study, we examined combinations of plasmids expressing multiple HIV-1 genes from different clades for their ability to elicit humoral and cellular immune responses in mice. Immunization with a modified Env, gp145
CFI, in combination with a Gag-Pol-Nef fusion protein plasmid elicited similar CD4+ and CD8+ cellular responses to immunization with either vector alone. Further, when mice were immunized with a mixture of Env from three clades, A, B, and C, together with Gag-Pol-Nef, the overall potency and balance of CD4+- and CD8+-T-cell responses to all viral antigens were similar, with only minor differences noted. In addition, plasmid mixtures elicited antibody responses comparable to those from individual inoculations. These findings suggest that a multigene and multiclade vaccine, including components from A, B, and C Env and Gag-Pol-Nef, can broaden antiviral immune responses without immune interference. Such combinations of immunogens may help to address concerns about viral genetic diversity for a prospective HIV-1 vaccine.
* Corresponding author. Mailing address: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg. 40, Room 4502, MSC 3005, 40 Convent Dr., Bethesda, MD 20892-3005. Phone: (301) 496-1852. Fax: (301) 480-0274. E-mail:
gnabel{at}nih.gov.
Journal of Virology, December 2003, p. 12764-12772, Vol. 77, No. 23
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.23.12764-12772.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Dai, B., Yang, L., Yang, H., Hu, B., Baltimore, D., Wang, P.
(2009). HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc. Natl. Acad. Sci. USA
106: 20382-20387
[Abstract]
[Full Text]
-
Kong, W.-P., Wu, L., Wallstrom, T. C., Fischer, W., Yang, Z.-Y., Ko, S.-Y., Letvin, N. L., Haynes, B. F., Hahn, B. H., Korber, B., Nabel, G. J.
(2009). Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination. J. Virol.
83: 2201-2215
[Abstract]
[Full Text]
-
Schoenly, K. A., Weiner, D. B.
(2008). Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform "Spotty Business". J. Virol.
82: 3166-3180
[Full Text]
-
Liang, R., van den Hurk, J. V., Landi, A., Lawman, Z., Deregt, D., Townsend, H., Babiuk, L. A., van Drunen Littel-van den Hurk, S.
(2008). DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J. Gen. Virol.
89: 453-466
[Abstract]
[Full Text]
-
Kong, W.-p., Hood, C., Yang, Z.-y., Wei, C.-J., Xu, L., Garcia-Sastre, A., Tumpey, T. M., Nabel, G. J.
(2006). Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc. Natl. Acad. Sci. USA
103: 15987-15991
[Abstract]
[Full Text]
-
Sathaliyawala, T., Rao, M., Maclean, D. M., Birx, D. L., Alving, C. R., Rao, V. B.
(2006). Assembly of Human Immunodeficiency Virus (HIV) Antigens on Bacteriophage T4: a Novel In Vitro Approach To Construct Multicomponent HIV Vaccines.. J. Virol.
80: 7688-7698
[Abstract]
[Full Text]
-
Weaver, E. A., Lu, Z., Camacho, Z. T., Moukdar, F., Liao, H.-X., Ma, B.-J., Muldoon, M., Theiler, J., Nabel, G. J., Letvin, N. L., Korber, B. T., Hahn, B. H., Haynes, B. F., Gao, F.
(2006). Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen. J. Virol.
80: 6745-6756
[Abstract]
[Full Text]
-
Sheets, R. L., Stein, J., Manetz, T. S., Duffy, C., Nason, M., Andrews, C., Kong, W.-P., Nabel, G. J., Gomez, P. L.
(2006). Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts. Toxicol Sci
91: 610-619
[Abstract]
[Full Text]
-
Burgers, W. A., van Harmelen, J. H., Shephard, E., Adams, C., Mgwebi, T., Bourn, W., Hanke, T., Williamson, A.-L., Williamson, C.
(2006). Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial. J. Gen. Virol.
87: 399-410
[Abstract]
[Full Text]
-
Kong, W.-p., Xu, L., Stadler, K., Ulmer, J. B., Abrignani, S., Rappuoli, R., Nabel, G. J.
(2005). Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization. J. Virol.
79: 13915-13923
[Abstract]
[Full Text]
-
Song, M. K., Vindurampulle, C. J., Capozzo, A. V. E., Ulmer, J., Polo, J. M., Pasetti, M. F., Barry, E. M., Levine, M. M.
(2005). Characterization of Immune Responses Induced by Intramuscular Vaccination with DNA Vaccines Encoding Measles Virus Hemagglutinin and/or Fusion Proteins. J. Virol.
79: 9854-9861
[Abstract]
[Full Text]
-
Barouch, D. H., Yang, Z.-y., Kong, W.-p., Korioth-Schmitz, B., Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Miura, A., Mascola, J. R., Letvin, N. L., Nabel, G. J.
(2005). A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates. J. Virol.
79: 8828-8834
[Abstract]
[Full Text]
-
Wu, L., Kong, W.-p., Nabel, G. J.
(2005). Enhanced Breadth of CD4 T-Cell Immunity by DNA Prime and Adenovirus Boost Immunization to Human Immunodeficiency Virus Env and Gag Immunogens. J. Virol.
79: 8024-8031
[Abstract]
[Full Text]
-
Brown, B. K., Darden, J. M., Tovanabutra, S., Oblander, T., Frost, J., Sanders-Buell, E., de Souza, M. S., Birx, D. L., McCutchan, F. E., Polonis, V. R.
(2005). Biologic and Genetic Characterization of a Panel of 60 Human Immunodeficiency Virus Type 1 Isolates, Representing Clades A, B, C, D, CRF01_AE, and CRF02_AG, for the Development and Assessment of Candidate Vaccines. J. Virol.
79: 6089-6101
[Abstract]
[Full Text]
-
Seaman, M. S., Xu, L., Beaudry, K., Martin, K. L., Beddall, M. H., Miura, A., Sambor, A., Chakrabarti, B. K., Huang, Y., Bailer, R., Koup, R. A., Mascola, J. R., Nabel, G. J., Letvin, N. L.
(2005). Multiclade Human Immunodeficiency Virus Type 1 Envelope Immunogens Elicit Broad Cellular and Humoral Immunity in Rhesus Monkeys. J. Virol.
79: 2956-2963
[Abstract]
[Full Text]
-
Richardson, B. A., Overbaugh, J.
(2005). Basic Statistical Considerations in Virological Experiments. J. Virol.
79: 669-676
[Full Text]
-
Akahata, W., Yang, Z.-y., Nabel, G. J.
(2005). Comparative Immunogenicity of Human Immunodeficiency Virus Particles and Corresponding Polypeptides in a DNA Vaccine. J. Virol.
79: 626-631
[Abstract]
[Full Text]